Blue Jet Healthcare Limited (BLUEJET.NS)
INR 584.5
(1.93%)
INR 584.5
(1.93%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.63 Billion INR | 2.33% |
| 2022 | 1.6 Billion INR | -11.88% |
| 2021 | 1.81 Billion INR | 31.19% |
| 2020 | 1.38 Billion INR | -4.44% |
| 2019 | 1.44 Billion INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 583.49 Million INR | 54.46% |
| 2024 Q1 | 377.77 Million INR | -4.72% |
| 2023 Q2 | 478.7 Million INR | 8.5% |
| 2023 Q3 | 321.09 Million INR | -32.92% |
| 2023 Q1 | 441.21 Million INR | -12.98% |
| 2023 Q4 | 396.49 Million INR | 23.48% |
| 2023 FY | 1.63 Billion INR | 2.33% |
| 2022 Q1 | 278.49 Million INR | 0.0% |
| 2022 FY | 1.6 Billion INR | -11.88% |
| 2022 Q4 | 507 Million INR | 35.09% |
| 2022 Q3 | 375.3 Million INR | -14.62% |
| 2022 Q2 | 439.54 Million INR | 57.83% |
| 2021 FY | 1.81 Billion INR | 31.19% |
| 2020 FY | 1.38 Billion INR | -4.44% |
| 2019 FY | 1.44 Billion INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Biocon Limited | 10.22 Billion INR | 83.985% |
| Concord Biotech Limited | 3.08 Billion INR | 46.852% |
| Dishman Carbogen Amcis Limited | -1.53 Billion INR | 206.713% |
| Jubilant Ingrevia Limited | 1.82 Billion INR | 10.464% |
| Lyka Labs Limited | -24.89 Million INR | 6677.93% |
| Panacea Biotec Limited | -11.73 Million INR | 14060.017% |
| Piramal Pharma Limited | 178.2 Million INR | -818.917% |
| SMS Lifesciences India Limited | 90.92 Million INR | -1700.886% |
| Supriya Lifescience Limited | 1.19 Billion INR | -37.474% |
| Syngene International Limited | 5.1 Billion INR | 67.892% |
| TAKE Solutions Limited | -1.19 Billion INR | 236.893% |
| Zota Health Care Limited | -143.47 Million INR | 1241.289% |